Compuestos y reactivos bioquímicos

Mouse PMN antibody (FITC) was raised in rabbit using mouse PMNs as the immunogen.

A synthetic peptide for use as a blocking control in assays to test for specificity of KCTD4 antibody, catalog no. 70R-5093

Rabbit polyclonal NKX31 antibody

The SCF antibody is a highly specialized monoclonal antibody that plays a crucial role in inhibiting the endocytic uptake of growth factors such as collagen and fatty acids. This antibody acts as a neutralizing agent and specifically targets the low-density lipoprotein receptor-related protein (LRP), preventing its activation by interfering with its binding to growth factors. By blocking this interaction, the SCF antibody effectively hinders the downstream signaling pathways involved in cell proliferation and differentiation.

Rabbit polyclonal SERPINB5 antibody

CRP antibody was raised in mouse using human CRP as the immunogen.

LAG3 antibody was raised in Rabbit using Human LAG3 as the immunogen

A synthetic peptide for use as a blocking control in assays to test for specificity of HEMGN antibody, catalog no. 70R-9545

A synthetic peptide for use as a blocking control in assays to test for specificity of PCMT1 antibody, catalog no. 70R-1558

CD12681 is a retinoic acid analogue that contains a heterobicyclic ring system. This molecule has been shown to have potential in the treatment of inflammatory diseases, including multiple sclerosis and rheumatoid arthritis. CD12681 binds to nuclear receptors, such as RAR-β and PPARγ, which are involved in cell proliferation and differentiation. It also inhibits the production of IL-17 by Th17 cells. These effects contribute to its therapeutic potential for autoimmune diseases.

mTOR inhibitor; anti-tumoral

BRD7116 is an anilide that targets leukemia stem cells and has shown to be effective in the treatment of leukemic patients. BRD7116 has been shown to inhibit proliferation and induce apoptosis in leukemia stem cells, which is a promising therapeutic approach for leukemia. The high-throughput screening assay was used to identify BRD7116 as a potential candidate for the treatment of this disease. This compound inhibits the growth of leukemic stem cells by downregulating proteins essential for cell cycle progression, including CDK2, cyclin D1, and Bcl-2.

A synthetic peptide for use as a blocking control in assays to test for specificity of CLPTM1L antibody, catalog no. 70R-7327

ELISA kit for detection of TIMP2 in the research laboratory

A synthetic peptide for use as a blocking control in assays to test for specificity of CAPNS2 antibody, catalog no. 70R-10067

GMFB antibody was raised in Rabbit using Human GMFB as the immunogen

Affinity purified Rabbit polyclonal CYP11B1 antibody

(2R,3S)-1-(((2aR,4S,4aS,6R,9S,11S,12S,12bS)-12b-Acetoxy-12-(benzoyloxy)-4,6,11-trihydroxy-4a,8,13

A synthetic peptide for use as a blocking control in assays to test for specificity of SESN2 antibody, catalog no. 70R-10132